Douglas F Nixon Selected Research

lopinavir-ritonavir drug combination (Kaletra)

10/2022

Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas F Nixon Research Topics

Disease

47	Infections 12/2021 - 01/2002
10	HIV Infections (HIV Infection) 10/2022 - 03/2006
10	Neoplasms (Cancer) 01/2022 - 03/2003
9	COVID-19 10/2022 - 01/2020
9	Viremia 12/2020 - 01/2002
8	Disease Progression 12/2014 - 01/2007
6	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2017 - 02/2012
3	Virus Diseases (Viral Diseases) 01/2021 - 03/2004
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2004 - 11/2002
2	Malaria 01/2022 - 01/2012
2	Zika Virus Infection 01/2019 - 01/2017
1	Coronavirus Infections 10/2022
1	Poliomyelitis (Polio) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Uveal melanoma 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Genetic Risk Score 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Carcinogenesis 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Inflammation (Inflammations) 01/2018
1	Shock 01/2018
1	Hyperalgesia 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Persistent Infection 01/2018
1	Pain (Aches) 01/2018
1	Microcephaly 01/2017
1	Common Variable Immunodeficiency 07/2016
1	Weight Loss (Weight Reduction) 04/2016

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2004
9	RNA (Ribonucleic Acid)IBA 12/2021 - 12/2003
9	CytokinesIBA 01/2021 - 02/2002
8	VaccinesIBA 01/2022 - 04/2004
6	AntigensIBA 01/2020 - 06/2004
5	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 01/2006
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
5	Peptides (Polypeptides)IBA 08/2017 - 01/2006
4	Antiviral Agents (Antivirals)IBA 12/2021 - 03/2004
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
4	AntibodiesIBA 08/2017 - 01/2012
3	Pharmaceutical PreparationsIBA 10/2022 - 11/2002
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2008
3	DNA Transposable Elements (Element, IS)IBA 12/2021 - 08/2012
3	InterferonsIBA 11/2015 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 06/2018
2	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 01/2018
2	InterleukinsIBA 01/2017 - 01/2008
2	Immunoglobulin G (IgG)IBA 07/2016 - 01/2012
2	EnzymesIBA 01/2016 - 07/2011
2	ElementsIBA 01/2014 - 08/2012
2	EpitopesIBA 03/2013 - 01/2010
2	AutoantigensIBA 08/2012 - 07/2009
2	LigandsIBA 02/2012 - 01/2007
2	HLA-B Antigens (HLA-B)IBA 02/2012 - 01/2010
2	KIR ReceptorsIBA 02/2010 - 01/2007
2	Interleukin-2 (IL2)IBA 01/2008 - 04/2006
2	Granzymes (Granzyme)IBA 03/2006 - 07/2004
2	PerforinIBA 03/2006 - 07/2004
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 10/2022
1	TESIBA 12/2021
1	Heme Oxygenase-1IBA 12/2021
1	Excipients (Suspending Agents)IBA 10/2021
1	LithiumIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	BCG Vaccine FDA Link 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Vascular Endothelial Growth Factor DIBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	nef Gene Products (nef Gene Product)IBA 08/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2018
1	Macrophage Colony-Stimulating FactorIBA 11/2018
1	CD4 Antigens (CD4 Antigen)IBA 11/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2018
1	allatostatinIBA 01/2018
1	HLA-C Antigens (HLA-C)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Ligand-Gated Ion ChannelsIBA 01/2018
1	Viral ProteinsIBA 08/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 07/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2016
1	HDL-triglycerideIBA 04/2016

Therapy/Procedure

10	Therapeutics 01/2020 - 01/2002
6	Art Therapy 12/2020 - 03/2006
6	Highly Active Antiretroviral Therapy (HAART) 12/2014 - 01/2002
3	Immunotherapy 01/2022 - 01/2020
2	Telescopes 12/2021 - 01/2020
2	Chemoprevention 06/2016 - 02/2016
1	Mass Drug Administration 01/2022